Sign inGet started

Fowler Neal Franklin

Insider CIK 1493692 · POZN Director · LQDA Chief Executive Officer, Director · EBS Director · ARLZ Director · LQDA Chief Executive Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
EBS Emergent BioSolutions Inc. A Award deriv2026-04-302026-05-0411,296— $011,296SEC↗
EBS Emergent BioSolutions Inc. A Award2026-04-302026-05-0425,344— $0160,847SEC↗
EBS Emergent BioSolutions Inc. A Award deriv2025-04-302025-05-0215,824— $041,572SEC↗
EBS Emergent BioSolutions Inc. A Award2025-04-302025-05-0234,403— $0135,503SEC↗
EBS Emergent BioSolutions Inc. S Sale2025-03-122025-03-1235,000$5.83 $204.1K101,100SEC↗
EBS Emergent BioSolutions Inc. A Award deriv2024-05-232024-05-2825,748— $025,748SEC↗
EBS Emergent BioSolutions Inc. A Award2024-05-232024-05-2817,430— $0136,100SEC↗
EBS Emergent BioSolutions Inc. A Award2023-10-032023-10-05118,670— $0118,670SEC↗
LQDA Liquidia Corp M Exercise deriv2020-11-192020-11-2062,885— $00SEC↗
LQDA Liquidia Corp F Tax w/h2020-11-192020-11-2035,684$3.40 $121.3K78,512SEC↗
LQDA Liquidia Corp M Exercise2020-11-192020-11-2062,885$1.85 $116.3K114,196SEC↗
LQDA Liquidia Technologies Inc A Award deriv2020-03-182020-03-20121,600— $0121,600SEC↗
LQDA Liquidia Technologies Inc A Award2020-03-182020-03-2030,400— $086,627SEC↗
LQDA Liquidia Technologies Inc A Award deriv2019-02-052019-02-0796,500— $096,500SEC↗
LQDA Liquidia Technologies Inc A Award2018-10-122018-10-1611,238— $056,227SEC↗
LQDA Liquidia Technologies Inc A Award deriv2018-07-252018-07-27192,008— $0192,008SEC↗
ARLZ Aralez Pharmaceuticals Inc A Award deriv2017-05-112017-05-1215,000— $015,000SEC↗
ARLZ Aralez Pharmaceuticals Inc A Award2017-05-112017-05-127,500— $073,869SEC↗
ARLZ Aralez Pharmaceuticals Inc A Award deriv2016-06-162016-06-2015,000— $015,000SEC↗
ARLZ Aralez Pharmaceuticals Inc A Award2016-06-162016-06-207,500— $066,369SEC↗
ARLZ Aralez Pharmaceuticals Inc F Tax w/h2016-06-102016-06-141,251$3.58 $4.5K49,479SEC↗
ARLZ Aralez Pharmaceuticals Inc J Other2016-02-052016-02-0950,730— $050,730SEC↗
POZN POZEN INC /NC M Exercise deriv2015-07-282015-07-3027,483— $00SEC↗
POZN POZEN INC /NC M Exercise deriv2015-07-282015-07-306,107— $00SEC↗
POZN POZEN INC /NC M Exercise deriv2015-07-282015-07-306,107— $00SEC↗
POZN POZEN INC /NC M Exercise deriv2015-07-282015-07-306,107— $00SEC↗
POZN POZEN INC /NC M Exercise2015-07-282015-07-306,107$4.44 $27.1K71,095SEC↗
POZN POZEN INC /NC M Exercise2015-07-282015-07-306,107$3.84 $23.5K58,881SEC↗
POZN POZEN INC /NC M Exercise2015-07-282015-07-306,107$5.40 $33.0K64,988SEC↗
POZN POZEN INC /NC F Tax w/h2015-07-282015-07-3020,365$12.17 $247.8K50,730SEC↗
POZN POZEN INC /NC M Exercise2015-07-282015-07-3027,483$5.97 $164.1K52,774SEC↗
POZN POZEN INC /NC A Award2015-06-102015-06-129,390— $034,681SEC↗
POZN POZEN INC /NC A Award2014-06-042014-06-069,291— $025,291SEC↗
POZN POZEN INC /NC A Award deriv2013-06-062013-06-105,000— $05,000SEC↗
POZN POZEN INC /NC A Award2013-06-062013-06-105,000— $016,000SEC↗
POZN POZEN INC /NC A Award deriv2012-06-072012-06-115,000— $05,000SEC↗
POZN POZEN INC /NC A Award2012-06-072012-06-115,000— $011,000SEC↗